Skip to main content
MLTX
NASDAQ Finance

Major Shareholder Sells $63M in MoonLake Immunotherapeutics Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$17.24
Mkt Cap
$1.245B
52W Low
$5.95
52W High
$62.75
52W Position info
190% above low
Off High info
73% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MLTX has more than doubled off its 52-week low of $5.95.

Summary

A major institutional investor and director, BVF Partners, sold $63 million worth of MoonLake Immunotherapeutics shares, representing over 5% of the company's market cap.


Key Events · Ownership and Investor Activity · MLTX

  • Significant Insider Sale

    BVF Partners, a 10% owner and director, sold 3,750,000 shares of MoonLake Immunotherapeutics stock.

  • Substantial Capital Outflow

    The sale generated $62,962,500 in proceeds, representing over 5% of the company's market capitalization.

  • Follows Prior Intent to Sell

    This transaction executes the intent to sell previously indicated in a Form 144 filing on April 1, 2026.

  • Reduction in Holdings

    The sale reduced BVF Partners' total holdings in MoonLake Immunotherapeutics by over 30%.


Analysis · MLTX · Finance

BVF Partners, a significant 10% owner and director by deputization, has executed a substantial sale of MoonLake Immunotherapeutics shares, disposing of 3.75 million shares for approximately $63 million. This transaction represents over 5% of the company's market capitalization and more than 30% of BVF's prior holdings. This follows a Form 144 filing yesterday indicating an intent to sell. Such a large disposition by a key institutional investor and director can signal a loss of conviction or a strategic portfolio rebalancing, potentially putting downward pressure on the stock.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MLTX was trading at $17.24 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $5.95 to $62.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MLTX - Latest Insights

MLTX
Nov 09, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $11.60
Real-time Price: $13.77 info
Change: +$2.17 (+19%) info
Market Cap: $1.171B info
MLTX
Nov 04, 2026, 7:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.62
Real-time Price: $13.77 info
Change: +$2.15 (+18%) info
Market Cap: $1.171B info
MLTX
Nov 04, 2026, 7:07 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $13.77 info
Change: +$2.16 (+19%) info
Market Cap: $1.171B info
MLTX
Sep 30, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.81
Real-time Price: $13.77 info
Change: +$1.95 (+17%) info
Market Cap: $1.171B info
MLTX
Aug 10, 2026, 1:21 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $17.11
Real-time Price: $13.77 info
Change: -$3.34 (-20%) info
Market Cap: $1.171B info